Home | Business News | Browse by Publication | M | M2 Presswire

Waters Corporation and Rosetta Biosoftware Announce a Collaboration to Advance the Analysis of Complex Biological Mixtures.

Article Excerpt
M2 PRESSWIRE-31 May 2007-Top Of Our Radar: Waters Corporation and Rosetta Biosoftware Announce a Collaboration to Advance the Analysis of Complex Biological Mixtures(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:31052007

Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the NYSE market has brought this company to the attention of our research team. Merck & Co., Inc. (NYSE: MRK), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer.

May 30 - Waters Corporation (NYSE:WAT) and Rosetta Biosoftware announced a collaboration to develop interfaces that promote compatibility between their software platforms and Waters mass spectrometry-based systems. Specifically, the companies will work together to ensure that Rosetta Biosoftware's solution for protein expression data management and analysis, the Rosetta Elucidator system, will process and analyze mass spectrometry data generated from the Waters Q-Tof Premier(TM) and Synapt(TM) High Definition Mass Spectrometry(TM) (HDMS) Systems.

The collaboration will focus on developing software...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!